脂质纳米囊 - 基托桑和IOTA - 卡拉基南水凝复合物用于持续的疏水药物输送
Grady K Mukubwa1, Justin B Safari1, Zikhona N Tetana2
1Rhodes University.
Research square
|September 2, 2025
概括
这项研究引入了一种新的脂质纳米囊 (LNC) 和水凝复合物,用于增强口服和肺部输送的疏水抗病毒药物. 该系统提高了药物溶解度和控制释放,克服了生理障碍,以获得更好的治疗结果.
科学领域:
- 药物输送和纳米技术
- 材料科学
- 制药科学
背景情况:
- 防水药物,特别是抗病毒药物,由于溶解性差和生理障碍,在口服和肺部输送方面面临挑战.
- 由于降解,pH值,传递时间或清除机制,现有的输送方法通常具有有限的治疗效果.
研究的目的:
- 开发一种新型复合系统,用于持续输送疏水性抗病毒药物.
- 使用脂质纳米囊 (LNC) 和水凝矩阵封装和控制EFV的释放.
- 在模拟生理条件下评估系统的性能,并评估其安全性.
主要方法:
- 脂质纳米囊 (LNC) 是为了封装Efavirenz (EFV) 而制成的.
- 用EFV加载的LNC被嵌入到酸盐/酸盐液中,以创建一个复合系统.
- 评估了药物溶解性,颗粒大小,水凝膨胀,封装效率,药物释放动力学和细胞毒性.
主要成果:
- 与水相比,LNC显著增加了EFV溶解度 (p < 0.0001),滴子大小控制 (57.4 ± 0.5 nm).
- 水凝复合物实现了约53%的封装效率和优化的膨胀率 (约300g/g).
- 与未配方药物相比,复合剂的EFV释放在不同的pH条件下显著延长 (p < 0. 0001),并且复合剂显示出细胞相容性.
结论:
- 开发的LNC-水凝复合物有效地提高了溶解度,并控制了疏水抗病毒药物的释放.
- 这种系统显示了通过口腔和肺部途径改善粘膜保留和持续药物输送的潜力.
- 这种复合物是克服难以溶解药物的挑战,提高治疗效率的多功能平台.
相关概念视频
Prevention of Further Absorption of Poison
1.4K
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
1.4K
Enhanced Elimination of Poison
1.1K
Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
1.1K
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
1.0K
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
1.0K
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
332
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
332
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
423
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
423
Pharmaceutical Poisoning: Treatment Strategies
279
Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
279


